The 20 Best Pancreatic Cancer Doctors Near Me in Michigan, US

Dr. Zalupski is an Professor of Medicine in the division of Medical Oncology at the UMMC. He completed medical school, an internal medicine residency and a medical oncology fellowship at Wayne State University in Detroit. Dr. Zalupski's clinical and research interest is in experimental therapeutics of gastrointestinal malignancies and sarcomas. He also serves as the medical director of the Multidisciplinary Pancreatic Cancer Clinic. Dr. Zalupski is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Neuroendocrine Tumor, Familial Pancreatic Cancer, and Pancreaticoduodenectomy.

Dr. Bednar is a faculty member in the Department of Surgery at the University of Michigan.His undergraduate training was done at Princeton University, where he graduated with a Bachelor of Arts degree in molecular biology in 2000. After that he transitioned to the Lewis Katz School of Medicine of Temple University in Philadelphia. Dr. Bednar spent seven years in the combined MD/PhD program where he earned an MD and PhD in Microbiology and Immunology in the laboratory of Dr. Thomas Rogers. His dissertation thesis focused on how human monocytes respond to the complex external environment present during an infection or inflammatory state. After the completion of his medical training he was accepted to the General Surgery Residency program at the University of Michigan. During his time in Ann Arbor, he also spent two years in a postdoctoral research fellowship in the laboratories of Dr. Diane Simeone and Dr. Marina Pasca di Magliano. During Dr. Bednar's research time, he studied the basic biology of pancreatic cancer, which led to his evolving interest in cancer patient care. He finished his clinical training in the Complex General Surgical Oncology Fellowship program at the University of Pittsburgh and was recruited back to the University of Michigan to become a part of the pancreatic cancer research group that has developed here in the past decade. Dr. Bednar is a board-certified general surgeon and currently undergoing board certification for additional specialization of Complex General Surgical Oncology. He is also BLS/ACLS certified.Dr. Bednar's clinical and research effort up to now has been recognized through several awards. He received the Dr. Herman Brown Award for Excellence in the Study of the Art and Science of Surgery from the Department of Surgery, Lewis Katz School of Medicine, Temple University as a recognition for his care of the surgical patients and his research work while he was a medical student. Dr. Bednar's work on pancreatic cancer was recognized and supported by an American College of Surgeons Research Fellowship. He also received the Robert V. Danto Cancer Research Award from the Michigan chapter of the American College of Surgeons for his postdoctoral research work. His work was chosen to be presented at the Owen Wangensteen Surgical Forum during the annual American College of Surgeons meeting in 2013 and received the Best Oral Presentation award at the 24th Annual Moses Gunn Research Conference of the Department of Surgery at the University of Michigan in 2012.Clinical Specialization:Dr. Bednar is a practicing general and oncologic surgeon. His practice encompasses the full gamut of general surgery and complex abdominal and soft tissue surgical oncology. During his fellowship training, he also received specific instruction on the DaVinci robotic surgery platform and hope to continue to support the already-established efforts in this arena. Dr. Bednar is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection.

Dr. Clifford S. Cho is the C. Gardner Child Professor of Surgery in the Division of Hepatopancreatobiliary and Advanced Gastrointestinal Surgery at Michigan Medicine.Dr. Cho is an Honors graduate of Brown University and AOA graduate of the Vanderbilt University School of Medicine. He completed his general surgery residency and transplantation immunology postdoctoral research fellowship at the University of Wisconsin, where he served as Chief Administrative Resident. He completed his surgical oncology fellowship at the Memorial Sloan-Kettering Cancer Center, where he served as Chief Administrative Fellow. He joined the faculty of the University of Wisconsin School of Medicine and Public Health in 2006, where he was promoted to Associate Professor with Tenure and named the Ronald and Patricia Kissinger Professor of Surgical Oncology. He served as Chief of the Division of Surgical Oncology, Associate Residency Program Director, and co-Director of the Gastrointestinal Disease Oriented Team in the University of Wisconsin Carbone Cancer Center before moving to the University of Michigan in 2016.Dr. Cho’s academic focus is on hepatopancreatobiliary and gastrointestinal malignancies, cancer immunology, and the mentorship of clinical and research trainees. He has lectured on these academic interests in over 15 national and international visiting professorships, and was named the James IV Traveler in 2014. He has published over 120 peer-reviewed manuscripts and book chapters and currently serves on the editorial boards of Surgery and the Journal of Gastrointestinal Surgery. He is the Principal Investigator of a VA Merit Review-funded cancer immunology laboratory that is working to understand cancer-induced T cell suppression, and to identify novel T cell-based strategies for cancer immunotherapy. His laboratory has been continuously funded since 2006 by extramural support from the Veteran’s Administration, National Institutes of Health, American College of Surgeons, and Central Surgical Association, and is a member of the VA Oncology Merit Review study section. He has held a number of national academic leadership positions and is a member of over 15 surgical societies, including the American Surgical Association, Society of Clinical Surgery, Society of University Surgeons, and Surgical Biology Club II. Dr. Cho is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreatectomy, and Pancreaticoduodenectomy.

Philip Philip is an Oncologist in Detroit, Michigan. Dr. Philip is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Neuroendocrine Tumor, Pancreatectomy, and Liver Embolization.

Surinder Batra is a Gastroenterologist in Detroit, Michigan. Dr. Batra is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Chronic Pancreatitis, Hepato-Pancreato-Biliary Surgery, and Endoscopy.

Dr. Sahai is the Leader of the Gastrointestinal Medical Oncology Section and Associate Professor in the Division of Hematology-Oncology, Department of Internal Medicine. Dr. Sahai is also a member of the University of Michigan Rogel Cancer Center and Director of Tumor Response Assessment Core.Dr. Sahai attended medical school at the Government Medical College at Amritsar with the Baba Farid University of Health Science in India. He then completed his Masters in Clinical Epidemiology at Harvard School of Public Health followed by Internal Medicine residency training at University of Pittsburgh where he met his wife. He completed his fellowship in Hematology-Oncology at Northwestern University where he also served as the Chief Fellow. Subsequently, Dr. Sahai joined University of Michigan as Assistant Professor in Internal Medicine in 2013.Dr. Sahai is a clinician-scientist who sees patients within the Multidisciplinary Pancreatic and Liver Tumor programs. As a clinical investigator he is the Principal Investigator on several investigator-initiated clinical trials open across the U.S. His translational research program leverages the pancreaticobiliary cancer biobanks that he directs for the therapeutic investigation of novel compounds in patient-derived cell lines and xenograft models to help develop novel phase 1/2 investigator-initiated clinical trials. Dr. Sahai is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Familial Pancreatic Cancer, and Neuroendocrine Tumor.

Sreenivasa Chandana is a Hematologist Oncology specialist and an Oncologist in Grand Rapids, Michigan. Dr. Chandana has been practicing medicine for over 22 years and is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, Familial Colorectal Cancer, Endoscopy, and Pancreatectomy. Dr. Chandana is currently accepting new patients.

Mathew Chung is a Surgical Oncologist in Grand Rapids, Michigan. Dr. Chung has been practicing medicine for over 34 years and is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, Pancreatectomy, and Small Bowel Resection.

Jeremy Barber is a Gastroenterologist and a Family Medicine provider in Traverse City, Michigan. Dr. Barber has been practicing medicine for over 20 years and is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Childhood Pancreatitis, Bile Duct Stricture, Cholestasis, Endoscopy, and Pancreatectomy. Dr. Barber is currently accepting new patients.

Andrew Muskovitz is a Hematologist and an Oncologist in Sterling Heights, Michigan. Dr. Muskovitz has been practicing medicine for over 21 years and is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Thrombocytopenia, Bone Marrow Aspiration, and Ureteroscopy. Dr. Muskovitz is currently accepting new patients.

Adil Akhtar is a Palliative Medicine specialist and an Oncologist in Sterling Heights, Michigan. Dr. Akhtar has been practicing medicine for over 41 years and is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Hemangioma Thrombocytopenia Syndrome, Thrombocytopenia, Lung Adenocarcinoma, Bone Marrow Aspiration, and Gastrostomy. Dr. Akhtar is currently accepting new patients.

Vandad Raofi is a Surgical Oncologist in Royal Oak, Michigan. Dr. Raofi is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Neuroendocrine Tumor, Pancreatic Cancer, Familial Pancreatic Cancer, Small Bowel Resection, and Pancreatectomy. Dr. Raofi is currently accepting new patients.

Ishmael Jaiyesimi is a Hematologist Oncology provider in Royal Oak, Michigan. Dr. Jaiyesimi has been practicing medicine for over 40 years and is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Thrombocytopenia, Familial Colorectal Cancer, and Bone Marrow Aspiration. Dr. Jaiyesimi is currently accepting new patients.

Edmund Paloyan is an Oncologist in Saint Joseph, Michigan. Dr. Paloyan has been practicing medicine for over 34 years and is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Paget Disease of the Breast, Familial Colorectal Cancer, Breast Cancer, and Lynch Syndrome. Dr. Paloyan is currently accepting new patients.

Laith Jamil is a Gastroenterologist in Royal Oak, Michigan. Dr. Jamil has been practicing medicine for over 34 years and is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Bile Duct Obstruction, Cholestasis, Hereditary Pancreatitis, Endoscopy, and Sleeve Gastrectomy. Dr. Jamil is currently accepting new patients.

Sara Riaz is a Hematologist and an Oncologist in Troy, Michigan. Dr. Riaz has been practicing medicine for over 22 years and is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Cancer. Her top areas of expertise are Familial Pancreatic Cancer, Pancreatic Cancer, Anemia, Breast Cancer, and Bone Marrow Aspiration. Dr. Riaz is currently accepting new patients.

George Howard is an Oncologist in Sterling Heights, Michigan. Dr. Howard has been practicing medicine for over 24 years and is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Adult Immune Thrombocytopenia, Familial Colorectal Cancer, Hemangioma Thrombocytopenia Syndrome, Bone Marrow Aspiration, and Gastrostomy. Dr. Howard is currently accepting new patients.

Dr. Kwon joined the Division of Gastroenterology in 2005 and is currently a Clinical Professor. He received his bachelor's degree from Amherst College and his medical degree from UCLA Medical School. He completed his internal medicine residency at Cedars-Sinai Medical Center and his gastroenterology fellowship at Brigham and Women's Hospital (BWH). He also completed his advanced endoscopy fellowship at the combined BWH and Massachusetts General Hospital program. He earned his Master of Science in Clinical Research Design and Statistical Analysis at the University of Michigan. Dr. Kwon is currently the Director of Advanced Endoscopy, Program Director for the Advanced Endoscopy fellowship, and Co-director of the Comprehensive Pancreas Program. He also serves as the Medical Director of the Michigan Chapter of the National Pancreas Foundation. He is a principal investigator in several independently funded research studies and has been an author on over 100 publications, including multiple research studies, national guidelines, and book chapters. He is a sought-after speaker, having served as invited faculty at multiple regional, national and international courses. Dr. Kwon is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Hereditary Pancreatitis, Bile Duct Obstruction, Pancreatic Cancer, Endoscopy, and Lithotripsy.

Dr. Hari Nathan is a board-certified complex general surgical oncologist and Associate Professor of Surgery with Tenure. Dr. Nathan completed both his undergraduate and medical education with honors at The Johns Hopkins University. He also completed advanced training in health services research and was awarded a PhD from The Johns Hopkins Bloomberg School of Public Health. Dr. Nathan completed his clinical residency training in general surgery at The Johns Hopkins Hospital. He subsequently completed a clinical fellowship in complex general surgical oncology at Memorial Sloan Kettering Cancer Center, where he also served as the Chief Administrative Fellow in Surgery. He joined the faculty of the University of Michigan in 2014. Clinical Specialization: Dr. Nathan's clinical focus includes the multi-disciplinary treatment of tumors of the pancreas, liver, bile duct, and stomach. He has particular interests in the treatment of liver metastases from colorectal cancer and directs Michigan Medicine’s Hepatic Artery Infusion Pump (HAIP) Program. He also serves as the Surgical Director of the Multidisciplinary Pancreatic Cancer Clinic, coordinating the efforts of a multidisciplinary team at the busiest pancreatic cancer program in Michigan. Dr. Nathan is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Neuroendocrine Tumor, Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy.

Thomas Enzler, MD PhD, is an Assistant Professor in the Division of Hematology and Oncology. He received his Master of Science from ETH Zurich and his Medical Degree from University of Basel, Switzerland. After completion of residency in Internal Medicine at University Hospitals of Zurich and Basel, Dr. Enzler did a research fellowship at the Dana Farber Cancer Institute, Harvard Medical School, Boston. There, he worked on projects focusing on tumor immune surveillance and his work resulted in several publications and in a PhD ‘magna cum laude’ in Biochemistry/Immunology (Harvard Medical School Boston/Max Delbrueck Center Berlin). He then moved to University of California San Diego to study signaling pathways of cancer cells and immune cells. While there, he successfully obtained ECFMG certification prior to doing clinic and laboratory research at Stanford University. From California Dr. Enzler went to Germany to do a Hematology and Oncology fellowship at University of Goettingen and he received board certification in both in Germany and in Switzerland. Dr. Enzler decided to return to the U.S. and completed U.S. residency in Internal Medicine at University of Arizona in Tucson. Following U.S. residency training, Dr. Enzler completed fellowship in Hematology and Oncology at Columbia University Medical Center, New York, where he worked on several research projects on gastrointestinal cancers. Dr. Enzler is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Familial Pancreatic Cancer, and Pancreatic Ductal Adenocarcinoma.